Inhaled β2 adrenergic agonists and other cAMP-elevating agents: therapeutics for alveolar injury and acute respiratory disease syndrome?

K Sriram, MB Insel, PA Insel - Pharmacological Reviews, 2021 - ASPET
Inhaled long-acting β-adrenergic agonists (LABAs) and short-acting β-adrenergic agonists
are approved for the treatment of obstructive lung disease via actions mediated by β 2 …
被引用次数：11 相关文章

Inhaled β 2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?

K Sriram, MB Insel, PA Insel - Pharmacological reviews, 2021 - pubmed.ncbi.nlm.nih.gov
Inhaled long-acting β-adrenergic agonists (LABAs) and short-acting β-adrenergic agonists
are approved for the treatment of obstructive lung disease via actions mediated by β2 …

Inhaled β2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?

K Sriram, MB Insel, PA Insel - Pharmacological Reviews, 2021 - europepmc.org
Inhaled long-acting β-adrenergic agonists (LABAs) and short-acting β-adrenergic agonists
are approved for the treatment of obstructive lung disease via actions mediated by β2 …
[PDF] researchgate.net

[PDF][PDF] Inhaled b2 Adrenergic Agonists and Other cAMP-Elevating Agents: Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?

K Sriram, MB Insel, PA Insel - PHARMACOLOGICAL REVIEWS, 2021 - researchgate.net
Inhaled long-acting b-adrenergic agonists (LABAs) and short-acting b-adrenergic agonists
are approved for the treatment of obstructive lung disease via actions mediated by b2 …